Effects of autologous serum on TREM2 and APOE in a personalized monocyte-derived macrophage assay of late-onset Alzheimer's patients

被引:1
|
作者
Eren, Neriman [1 ,2 ,3 ]
Gerike, Susanna [1 ,2 ,3 ]
Uesekes, Berk [1 ,2 ,3 ]
Peters, Oliver [1 ,2 ,3 ,4 ]
Cosma, Nicoleta-Carmen [1 ,2 ,3 ,5 ]
Hellmann-Regen, Julian [1 ,2 ,3 ,5 ]
机构
[1] Charite Univ Med Berlin, Dept Psychiat & Psychotherapy, Campus Benjamin Franklin,Hindenburgdamm 30, D-12203 Berlin, Germany
[2] Humboldt Univ, Freie Univ Berlin, Campus Benjamin Franklin,Hindenburgdamm 30, D-12203 Berlin, Germany
[3] Berlin Inst Hlth, Sect Clin Neurobiol, Campus Benjamin Franklin,Hindenburgdamm 30, D-12203 Berlin, Germany
[4] German Ctr Mental Hlth DZPG, Partner Site Berlin, Berlin, Germany
[5] Charite Univ Med Berlin, BIH Biomed Innovat Acad, BIH Charite Clinician Scientist Program, Berlin Inst Hlth, Charitepl 1, D-10117 Berlin, Germany
关键词
Late-onset Alzheimer's disease; TREM2; APOE; Monocyte-derived macrophages; Amyloid-beta uptake; Sex differences; Patient-derived personalized assay; Inflammaging; APOLIPOPROTEIN-E; SYSTEMIC INFLAMMATION; MICROGLIAL CELLS; AMYLOID-BETA; DISEASE; DYSREGULATION; ASSOCIATION; PHENOTYPES; SECRETION; VARIANTS;
D O I
10.1186/s12979-023-00376-2
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
Background Age-associated deterioration of the immune system contributes to a chronic low-grade inflammatory state known as "inflammaging" and is implicated in the pathogenesis of late-onset Alzheimer's disease (LOAD). Whether changes in the tissue environment caused by circulatory factors associated with aging may alter the innate immune response is unknown. Monocyte-derived macrophages (Mo-MCYRILLIC CAPITAL LETTER EFs) infiltrating the brain alongside microglia are postulated to play a modulatory role in LOAD and both express triggering receptor expressed on myeloid cells 2 (TREM2). Apolipoprotein E (APOE) acts as a ligand for TREM2, and their role in amyloid beta (A beta) clearance highlights their importance in LOAD. However, the influence of the patient's own milieu (autologous serum) on the synthesis of TREM2 and APOE in infiltrating macrophages remains unknown. Objectives To functionally assess patient-specific TREM2 and APOE synthesis, we designed a personalized assay based on Mo-MCYRILLIC CAPITAL LETTER EFs using monocytes from LOAD patients and matched controls (CO). We assessed the influence of each participant's own milieu, by examining the effect of short- (1 day) and long- (10 days) term differentiation of the cells in the presence of the donor ' s autologous serum (AS) into M1-, M2- or M0-macrophages. Additionally, sex differences and A beta-uptake ability in short- and long-term differentiated Mo-MCYRILLIC CAPITAL LETTER EFs were assessed. Results We showed a time-dependent increase in TREM2 and APOE protein levels in LOAD- and CO-derived cells. While AS did not differentially modulate TREM2 compared to standard fetal calf serum (FCS), AS decreased APOE levels in M2 macrophages but increased levels in M1 macrophages. Interestingly, higher levels of TREM2 and lower levels of APOE were detected in female- than in male- LOAD patients. Finally, we report decreased A beta-uptake in long-term differentiated CO- and LOAD-derived cells, particularly in APOE epsilon 4(+) carriers. Conclusions We demonstrate for the first time the suitability of a personalized Mo-MCYRILLIC CAPITAL LETTER EF cell culture-based assay for studying functional TREM2 and APOE synthesis in a patient's own aged milieu. Our strategy may thus provide a useful tool for future research on diagnostic and therapeutic aspects of personalized medicine.
引用
收藏
页数:18
相关论文
共 36 条
  • [1] Effects of autologous serum on TREM2 and APOE in a personalized monocyte-derived macrophage assay of late-onset Alzheimer’s patients
    Neriman Eren
    Susanna Gerike
    Berk Üsekes
    Oliver Peters
    Nicoleta-Carmen Cosma
    Julian Hellmann-Regen
    Immunity & Ageing, 20
  • [2] Peripheral TREM2 mRNA levels in early and late-onset Alzheimer disease’s patients
    Gamze Guven
    Basar Bilgic
    Bedia Samanci
    Hakan Gurvit
    Hasmet Hanagasi
    Cagla Donmez
    Rukiye Aslan
    Ebba Lohmann
    Nihan Erginel-Unaltuna
    Molecular Biology Reports, 2020, 47 : 5903 - 5909
  • [3] Acute and Chronic Macrophage Differentiation Modulates TREM2 in a Personalized Alzheimer's Patient-Derived Assay
    Cosma, Nicoleta-Carmen
    Eren, Neriman
    Usekes, Berk
    Gerike, Susanna
    Heuser, Isabella
    Peters, Oliver
    Hellmann-Regen, Julian
    CELLULAR AND MOLECULAR NEUROBIOLOGY, 2023, 43 (06) : 3047 - 3060
  • [4] Peripheral TREM2 mRNA levels in early and late-onset Alzheimer disease's patients
    Guven, Gamze
    Bilgic, Basar
    Samanci, Bedia
    Gurvit, Hakan
    Hanagasi, Hasmet
    Donmez, Cagla
    Aslan, Rukiye
    Lohmann, Ebba
    Erginel-Unaltuna, Nihan
    MOLECULAR BIOLOGY REPORTS, 2020, 47 (08) : 5903 - 5909
  • [5] Acute and Chronic Macrophage Differentiation Modulates TREM2 in a Personalized Alzheimer’s Patient-Derived Assay
    Nicoleta-Carmen Cosma
    Neriman Eren
    Berk Üsekes
    Susanna Gerike
    Isabella Heuser
    Oliver Peters
    Julian Hellmann-Regen
    Cellular and Molecular Neurobiology, 2023, 43 : 3047 - 3060
  • [6] Lack of Genetic Association Between TREM2 and Late-Onset Alzheimer's Disease in a Japanese Population
    Miyashita, Akinori
    Wen, Yanan
    Kitamura, Nobutaka
    Matsubara, Etsuro
    Kawarabayashi, Takeshi
    Shoji, Mikio
    Tomita, Naoki
    Furukawa, Katsutoshi
    Arai, Hiroyuki
    Asada, Takashi
    Harigaya, Yasuo
    Ikeda, Masaki
    Amari, Masakuni
    Hanyu, Haruo
    Higuchi, Susumu
    Nishizawa, Masatoyo
    Suga, Masaichi
    Kawase, Yasuhiro
    Akatsu, Hiroyasu
    Imagawa, Masaki
    Hamaguchi, Tsuyoshi
    Yamada, Masahito
    Morihara, Takashi
    Takeda, Masatoshi
    Takao, Takeo
    Nakata, Kenji
    Sasaki, Ken
    Watanabe, Ken
    Nakashima, Kenji
    Urakami, Katsuya
    Ooya, Terumi
    Takahashi, Mitsuo
    Yuzuriha, Takefumi
    Serikawa, Kayoko
    Yoshimoto, Seishi
    Nakagawa, Ryuji
    Saito, Yuko
    Hatsuta, Hiroyuki
    Murayama, Shigeo
    Kakita, Akiyoshi
    Takahashi, Hitoshi
    Yamaguchi, Haruyasu
    Akazawa, Kohei
    Kanazawa, Ichiro
    Ihara, Yasuo
    Ikeuchi, Takeshi
    Kuwano, Ryozo
    JOURNAL OF ALZHEIMERS DISEASE, 2014, 41 (04) : 1031 - 1038
  • [7] Association of Variants in PINX1 and TREM2 With Late-Onset Alzheimer Disease
    Tosto, Giuseppe
    Vardarajan, Badri
    Sariya, Sanjeev
    Brickman, Adam M.
    Andrews, Howard
    Manly, Jennifer J.
    Schupf, Nicole
    Reyes-Dumeyer, Dolly
    Lantigua, Rafael
    Bennett, David A.
    De Jager, Phillip L.
    Mayeux, Richard
    JAMA NEUROLOGY, 2019, 76 (08) : 942 - 948
  • [8] The Association between TREM2 Gene and Late-Onset Alzheimer's Disease in Chinese Han Population
    Sun, Yan
    Zhang, Yun-Ke
    Chen, Hai
    Chen, Ren-Shou
    GERONTOLOGY, 2022, 68 (03) : 302 - 308
  • [9] Association Study of the TREM2 Gene and Identification of a Novel Variant in Exon 2 in Iranian Patients with Late-Onset Alzheimer's Disease
    Mehrjoo, Zohreh
    Najmabadi, Amin
    Abedini, Seyedeh Sedigheh
    Mohseni, Marzieh
    Kamali, Koorosh
    Najmabadi, Hossein
    Khorshid, Hamid Reza Khorram
    MEDICAL PRINCIPLES AND PRACTICE, 2015, 24 (04) : 351 - 354
  • [10] The late-onset Alzheimer's disease risk factor RHBDF2 is a modifier of microglial TREM2 proteolysis
    Jocher, Georg
    Ozcelik, Gozde
    Mueller, Stephan A.
    Hsia, Hung-En
    Lastra Osua, Miranda
    Hofmann, Laura, I
    Assfalg, Marlene
    Dinkel, Lina
    Feng, Xiao
    Schlepckow, Kai
    Willem, Michael
    Haass, Christian
    Tahirovic, Sabina
    Blobel, Carl P.
    Lichtenthaler, Stefan F.
    LIFE SCIENCE ALLIANCE, 2025, 8 (05)